Steoarthritis. N Engl J Med 2006, 354:795?08. DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B: Tramadol hydrochloride extended-release once-daily in the therapy of osteoarthritis on the knee and/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther 2011, 18:216?26. Essex MN, Bhadra P, Sands GH: Efficacy and tolerability of celecoxib versus naproxen in individuals with osteoarthritis on the knee: a randomized, double-blind, double-dummy trial. J Int Med Res 2012, 40:1357?370. Fishman RL, Kistler CJ, Ellerbusch MT, Aparicio RT, Swami SS, Shirley ME, Jain AK, Fortier L, Robertson S, Bouchard S: Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag 2007, three:273. Fleischmann R, Sheldon E, Maldonado-Cocco J, Dutta D, Yu S, Sloan VS: Lumiracoxib is productive inside the therapy of osteoarthritis with the knee: a potential randomized 13-week study versus placebo and celecoxib. Clin Rheumatol 2006, 25:42?3. Fleischmann RM, Caldwell JR, Roth SH, Tesser JR, Olson W, Kamin M: Tramadol for the therapy of joint discomfort associated with osteoarthritis: a randomized, double-blind, placebo-controlled trial. Curr Ther Res 2001, 62:113?28. Hochberg MC, Fort JG, Svensson O, Hwang C, Sostek M: Fixed-dose mixture of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials. Curr Med Res Opin 2011, 27:1243?253. Kivitz A, Eisen G, Zhao WW, Bevirt T, Recker DP: Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. J Fam Pract 2002, 51:530?37. Kivitz AJ, Moskowitz RW, Woods E, Hubbard RC, Verburg KM, Lefkowith JB, Geis GS: Comparative efficacy and security of celecoxib and naproxen inside the therapy of osteoarthritis with the hip. J Int Med Res 2001, 29:467?79. Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, Litschig S, Sloan VS: Efficacy and tolerability of lumiracoxib 100 mg as soon as everyday in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. Curr Med Res Opin 2005, 21:517?26. Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, Castro R, Sanchez M, Detora LM, Ng J: Efficacy and tolerability profile of etoricoxib in sufferers with osteoarthritis: a randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.(1S,2R)-2-Amino-1,2-diphenylethanol Formula Curr Med Res Opin 2002, 18:49?eight.Bromo-PEG2-C2-acid Chemscene Markenson JA, Croft J, Zhang PG, Richards P: Remedy of persistent discomfort linked to osteoarthritis with controlled-release oxycodone tablets inside a randomized controlled clinical trial.PMID:24507727 Clin J Pain 2005, 21:524. Puopolo A, Boice JA, Fidelholtz JL, Littlejohn TW, Miranda P, Berrocal A, Ko A, Cichanowitz N, Reicin AS: A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. Osteoarthr Cartil 2007, 15:1348?356. Rauck R, Rapoport R, Thipphawong J: Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS?hydromorphone ER in patients with moderate to severe discomfort linked to chronic osteoarthritis. Discomfort Pract 2013, 13:18?9.70. Schnitzer TJ, Dattani ID, Seriolo B, Schneider H, Moore A, Tseng L, Sallstig P, Rebuli R, Maxwell T: A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis. Clin Rheumatol 2011, 30:143.